BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zafar S, Beg S, Panda SK, Rahman M, Alharbi KS, Jain GK, Ahmad FJ. Novel therapeutic interventions in cancer treatment using protein and peptide-based targeted smart systems. Semin Cancer Biol 2021;69:249-67. [PMID: 31442570 DOI: 10.1016/j.semcancer.2019.08.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang M, Xu H. Peptide-assembled nanoparticles targeting tumor cells and tumor microenvironment for cancer therapy. Front Chem 2023;11. [DOI: 10.3389/fchem.2023.1115495] [Reference Citation Analysis]
2 Zhang M, Jiang H, Wu L, Lu H, Bera H, Zhao X, Guo X, Liu X, Cun D, Yang M. Airway epithelial cell-specific delivery of lipid nanoparticles loading siRNA for asthma treatment. J Control Release 2022;352:422-37. [PMID: 36265740 DOI: 10.1016/j.jconrel.2022.10.020] [Reference Citation Analysis]
3 Wu X, Iliuk AB, Tao WA. Translational proteomics and phosphoproteomics: Tissue to extracellular vesicles. Adv Clin Chem 2023;112:119-53. [PMID: 36642482 DOI: 10.1016/bs.acc.2022.09.003] [Reference Citation Analysis]
4 Velayutham M, Haridevamuthu B, Priya PS, Ganesh MR, Juliet A, Arockiaraj J. Serine O-acetyltransferase derived NV14 peptide reduces cytotoxicity in H2O2 induced MDCK cells and inhibits MCF-7 cell proliferation through caspase gene expression. Mol Biol Rep 2022. [PMID: 35941417 DOI: 10.1007/s11033-022-07746-x] [Reference Citation Analysis]
5 Naeimi R, Bahmani A, Afshar S. Investigating the role of peptides in effective therapies against cancer. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02553-7] [Reference Citation Analysis]
6 Bibi N, ur Rehman A, Rana NF, Akhtar H, Khan MI, Faheem M, Jamal SB, Ahmed N. Formulation and characterization of curcumin nanoparticles for skin cancer treatment. Appl Nanosci. [DOI: 10.1007/s13204-022-02346-4] [Reference Citation Analysis]
7 Guo Y, Hu Z, Wang Z. Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood. Front Mol Neurosci 2021;14:778955. [PMID: 35002620 DOI: 10.3389/fnmol.2021.778955] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Trinidad-Calderón PA, Varela-Chinchilla CD, García-Lara S. Natural Peptides Inducing Cancer Cell Death: Mechanisms and Properties of Specific Candidates for Cancer Therapeutics. Molecules 2021;26:7453. [PMID: 34946535 DOI: 10.3390/molecules26247453] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
9 Trinidad-calderón PA, Varela-chinchilla CD, García-lara S. Natural Peptides Inducing Cancer Cell Death: Mechanisms and Properties of Specific Candidates for Cancer Therapeutics. Molecules 2021;26:7453. [DOI: 10.3390/molecules26247453] [Reference Citation Analysis]
10 Wang H, Zhao J, Zhao H, Li H, Wang J. CL-ACP: a parallel combination of CNN and LSTM anticancer peptide recognition model. BMC Bioinformatics 2021;22:512. [PMID: 34670488 DOI: 10.1186/s12859-021-04433-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Doroshenko IA, Aminulla KG, Azev VN, Kulinich TM, Vasilichin VA, Shtil AA, Podrugina TA. Synthesis of modified conformationally fixed tricarbocyanine dyes for conjugation with therapeutic agents. Mendeleev Communications 2021;31:615-617. [DOI: 10.1016/j.mencom.2021.09.008] [Reference Citation Analysis]
12 AlSawaftah N, Pitt WG, Husseini GA. Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment. ACS Pharmacol Transl Sci 2021;4:1028-49. [PMID: 34151199 DOI: 10.1021/acsptsci.1c00066] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
13 Rahman M, Souto EB, Alam K, Beg S. Lipid–polymer hybrid nanoparticles: Production, characterization and formulation of nucleic acids for cancer therapy. Nanoformulation Strategies for Cancer Treatment 2021. [DOI: 10.1016/b978-0-12-821095-6.00011-2] [Reference Citation Analysis]
14 Rahman M, Alam K, Ilyas R, Beg S. Phytoactives-loaded nanocarriers for liver cancer treatment. Nanoformulation Strategies for Cancer Treatment 2021. [DOI: 10.1016/b978-0-12-821095-6.00015-x] [Reference Citation Analysis]
15 Rahman M, Alam K, Hafeez A, Ilyas R, Beg S. Protein-based nanomedicines as anticancer drug delivery platforms. Nanoformulation Strategies for Cancer Treatment 2021. [DOI: 10.1016/b978-0-12-821095-6.00005-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Rahman M, Souto EB, Alam K, Beg S. Biopharmaceutical challenges in using lipid nanoparticles for oral chemotherapy. Nanoformulation Strategies for Cancer Treatment 2021. [DOI: 10.1016/b978-0-12-821095-6.00014-8] [Reference Citation Analysis]
17 Rahman M, Beg S, Alam K, Jalees Ahmad F. Nanomedicine for combinational anticancer drug therapeutics: Recent advances, challenges, and future perspectives. Nanoformulation Strategies for Cancer Treatment 2021. [DOI: 10.1016/b978-0-12-821095-6.00001-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Rahman M, Souto EB, Alam K, Beg S. Liposomal nanotherapeutics in cancer treatment. Nanoformulation Strategies for Cancer Treatment 2021. [DOI: 10.1016/b978-0-12-821095-6.00002-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Akhter MH, Beg S, Tarique M, Malik A, Afaq S, Choudhry H, Hosawi S. Receptor-based targeting of engineered nanocarrier against solid tumors: Recent progress and challenges ahead. Biochim Biophys Acta Gen Subj 2021;1865:129777. [PMID: 33130062 DOI: 10.1016/j.bbagen.2020.129777] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
20 Pérez-López A, Martín-Sabroso C, Torres-Suárez AI, Aparicio-Blanco J. Timeline of Translational Formulation Technologies for Cancer Therapy: Successes, Failures, and Lessons Learned Therefrom. Pharmaceutics 2020;12:E1028. [PMID: 33126622 DOI: 10.3390/pharmaceutics12111028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Fang W, Che X, Li G, Wang A, Wang Y, Shi X, Hou K, Zhang X, Qu X, Liu Y. Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex. J Exp Clin Cancer Res 2020;39:82. [PMID: 32381104 DOI: 10.1186/s13046-020-01581-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]